Is Microdosing Ozempic The New Weight Loss Trend? Experts Weigh In

A new weight loss trend has emerged, with some people opting for “microdosing” Ozempic, a medication primarily prescribed for type 2 diabetes. This practice involves using smaller doses of Ozempic than those typically recommended for managing diabetes or promoting weight loss. Although this trend is gaining attention, it has raised concerns among health experts.

The Rise of Ozempic and Weight Loss Medications

In the U.S., nearly 70% of adults are classified as overweight or obese, which has led many to seek medical help in managing their weight. Ozempic is a medication made by Novo Nordisk, initially approved for type 2 diabetes, while Wegovy, its counterpart, is approved for obesity treatment. Another weight-loss medication, Mounjaro by Eli Lilly, is also popular. Ozempic is the only weekly injectable among these medications that allows patients to reduce the dose.

What is Microdosing Ozempic?

Microdosing Ozempic involves using much smaller doses of the medication compared to standard prescriptions. Experts caution that this practice has not been approved by the U.S. Food and Drug Administration (FDA) and is not typically recommended by healthcare professionals. Dr. Fatima Cody Stanford, an obesity medicine specialist at Massachusetts General Hospital, emphasized that clinical trials have determined the most effective doses for managing diabetes and aiding weight loss, which are not to be altered.

Why Do People Try Microdosing Ozempic?

The main reason some individuals turn to microdosing is to save money. A full prescription of Ozempic can cost over $250 per week, so some patients think they can still achieve weight loss benefits with a fraction of the prescribed dose. Additionally, microdosing may help reduce side effects such as nausea, vomiting, or stomach discomfort, according to experts.

However, microdosing may not offer the same level of effectiveness as the full therapeutic dose. Lower doses may also diminish the potential benefits of the medication.

The Risks of Microdosing

While microdosing may seem like an affordable alternative, health experts warn against the practice. Dr. Christopher McGowan, a gastroenterologist and obesity specialist, noted that microdosing is an unproven, off-label use of Ozempic. There are no clinical studies supporting the safety or effectiveness of this approach. Furthermore, using smaller doses could lead to uncontrolled blood sugar and inadequate weight loss, potentially causing complications in people with diabetes.

Some individuals also resort to “compounded” versions of Ozempic, which are not FDA-regulated. This creates risks of contamination, inconsistent formulations, and uncertainty regarding the actual strength of the medication.

Microdosing as a Temporary Solution

Although some people may use microdosing to stretch their supply of medication, experts caution that it is not a long-term solution. Dr. Amy Rothberg from the University of Michigan noted that the placebo effect might influence the perceived benefits of microdosing. Additionally, without changes to diet and exercise, the benefits of the medication are likely to disappear once it is discontinued.

Dr. Suzanne Trott, a Beverly Hills surgeon, shared that she has seen patients use microdosing with minimal risks when closely monitored by healthcare providers. However, she stressed that it should only be done under professional supervision.

Sustaining Weight Loss Through Lifestyle Changes

Experts agree that medications alone will not result in sustained weight loss. Dr. Rothberg emphasized the importance of accompanying behavioral changes, such as improved diet and regular physical activity, to maintain weight loss after using medications like Ozempic.

In conclusion, while microdosing Ozempic may seem like a tempting option for some, it comes with risks and uncertain benefits. Before considering this practice, it is crucial to consult with a healthcare provider to ensure safety and efficacy.